Nouveau Life Pharmaceuticals, Inc. (NOUV)

NOUV Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Oct 16, 2026	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003
Market Capitalization	0	9	12	8	3	6
Market Cap Growth	0%	-21.38%	55.63%	173.43%	-53.01%	-43.96%
Enterprise Value	-	10	12	8	3	6
Last Close Price	0.00	0.31	0.45	0.30	0.12	0.27

Price Ratios

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Oct 16, 2026	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003
PB Ratio	0.16	29.50	-13.64	-7.93	-3.32	-7.41

Financial Efficiency

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Oct 16, 2026	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003
Debt / Equity Ratio	9.17	1.25	-0.43	-0.65	-0.29	-0.30
Net Debt / Equity Ratio	9.16	1.24	-0.43	-0.65	-0.28	-0.30
Net Debt / EBITDA Ratio	-2.38	-2.43	-	-	-	-
Net Debt / FCF Ratio	-17.22	-17.05	-4.36	-9.69	-2.91	-20.85
Quick Ratio	0	0.01	0.01	0.00	0.01	0.00
Current Ratio	0	0.01	0.04	0.00	0.01	0.00
Return on Assets (ROA)	-19.82%	-24.72%	-737.36%	-3784.55%	-3175.31%	-7359.43%
Return on Capital Employed (ROCE)	-150.30%	-49.00%	27.40%	36.40%	37.70%	53.00%

Yields

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Oct 16, 2026	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003
Earnings Yield	-7556.15%	-3.84%	-2.17%	-5.27%	-11.21%	-4.29%
FCF Yield	-340.79%	-0.25%	-0.72%	-0.84%	-2.91%	-0.19%
Buyback Yield / Dilution	-9.94%	-9.14%	-6.60%	-7.74%	-4.56%	-3.04%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2012

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error